Trastuzumab-PEG12-DBCO is an Anti-Her2 human monoclonal antibody (Trastuzumab) stochastic conjugated NHS-PEG12-DBCO with the lysine residences of the antibody. The DAR of Trastuzumab-PEG12-DBCO is 3 ~ 5. >98% of antibody is conjugated. This DBCO functionalized antibody can be used as a scaffolding to conjugation with any payloads contain azido group by one-step click chemistry. This product is for research use only.
Product Details |
Species Reactivity | Human |
---|
Host/Isotype | Cell culture/ IgG1 |
---|
Class | Monoclonal |
---|
Type | Antibody-Linker conjugate |
---|
Immunogen | Human Her2 |
---|
DAR (Drug to Antibody Ratio) | 3 ~ 5 |
---|
Clone | Trastuzumab biosimilar |
---|
Conjugate | Trastuzumab conjugated with NHS-PEG12-DBCO |
---|
Purity | >98% |
---|
Molecular Weight | ~150kDa |
---|
Protein Concentration | 2 mg/ml |
---|
Storage Condition | 4°C for short time, -20°C or -80°C for long time. |
---|
Storage Buffer | PBS buffer pH7.4 |